Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
The present invention provides novel α-glucosidase inhibitory compound (−)-mesquitol and its analogs isolated in significant yield from traditional medicinal plantDichrostachys cinereaand further modification of (−)-mesquitol to enhance the α-glucosidase inhibitory potential; the invention also identifies the usage of (−)-mesquitol and its analogues, based on their α-glucosidase inhibitory activity, as broad based potential therapeutics as antihyperglycernic, antidiabatic, antiobesity, antiviral, anticancer, immunestimulants and the like.
Collins, FM ‘Current treatment approaches to type 2 diabetes mellitus: success and shortcomings’ PMID: 12408409 (2002).
Scheen, AJ ‘Treatment of diabetes in patients with severe obesity’ Biomed & Pharmacother (2000) 54:74-79.
Kumar Upparapalli Sampath
Raghavan Kondapuram Vijaya
Rao Janaswamy Madhusudana
Rao Rao Jagadeeshwar
Reddy Singireddy Venkat
Council of Scientific and Industrial Research
Owens Amelia A.
α-Glucosidase inhibitors and their synthesis from a... does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with α-Glucosidase inhibitors and their synthesis from a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and α-Glucosidase inhibitors and their synthesis from a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3586766